These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35540746)

  • 1. Enrichment of human Vγ9Vδ2 T lymphocytes by magnetic poly(divinylbenzene-
    Sawaisorn P; Tangchaikeeree T; Polpanich D; Midoeng P; Udomsangpetch R; Elaissari A; Jangpatarapongsa K
    RSC Adv; 2018 Apr; 8(26):14393-14400. PubMed ID: 35540746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive magnetic poly(divinylbenzene-co-glycidyl methacrylate) colloidal particles for specific antigen detection using microcontact printing technique.
    Eissa MM; Mahbubor Rahman M; Zine N; Jaffrezic N; Errachid A; Fessi H; Elaissari A
    Acta Biomater; 2013 Mar; 9(3):5573-82. PubMed ID: 23107799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.
    Liu Z; Guo BL; Gehrs BC; Nan L; Lopez RD
    J Urol; 2005 May; 173(5):1552-6. PubMed ID: 15821484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells.
    Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S
    Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia.
    Sawaisorn P; Tangchaikeeree T; Chan-On W; Leepiyasakulchai C; Udomsangpetch R; Hongeng S; Jangpatarapongsa K
    Immunol Invest; 2019 Jan; 48(1):11-26. PubMed ID: 30321079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications.
    de Bruin RCG; Lougheed SM; van der Kruk L; Stam AG; Hooijberg E; Roovers RC; van Bergen En Henegouwen PMP; Verheul HMW; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2016 Aug; 169():128-138. PubMed ID: 27373969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells.
    Tomogane M; Sano Y; Shimizu D; Shimizu T; Miyashita M; Toda Y; Hosogi S; Tanaka Y; Kimura S; Ashihara E
    Biochem Biophys Res Commun; 2021 Oct; 573():132-139. PubMed ID: 34407491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.
    Schilbach KE; Geiselhart A; Wessels JT; Niethammer D; Handgretinger R
    J Immunother; 2000; 23(5):536-48. PubMed ID: 11001547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization.
    Lin L; He J; Li J; Xu Y; Li J; Wu Y
    Int J Nanomedicine; 2019; 14():9325-9336. PubMed ID: 31819434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
    Cabillic F; Toutirais O; Lavoué V; de La Pintière CT; Daniel P; Rioux-Leclerc N; Turlin B; Mönkkönen H; Mönkkönen J; Boudjema K; Catros V; Bouet-Toussaint F
    Cancer Immunol Immunother; 2010 Nov; 59(11):1611-9. PubMed ID: 20582413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.
    Zhai X; You F; Xiang S; Jiang L; Chen D; Li Y; Fan S; Han Z; Zhang T; An G; Zhang B; Chen Y; Meng H; Yang L
    Am J Cancer Res; 2021; 11(1):79-91. PubMed ID: 33520361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
    Santolaria T; Robard M; Léger A; Catros V; Bonneville M; Scotet E
    J Immunol; 2013 Aug; 191(4):1993-2000. PubMed ID: 23836057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
    Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
    Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.
    Dimova T; Brouwer M; Gosselin F; Tassignon J; Leo O; Donner C; Marchant A; Vermijlen D
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):E556-65. PubMed ID: 25617367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance.
    Nussbaumer O; Thurnher M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32235722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of gamma delta T cells with multivalent immunity.
    Deniger DC; Moyes JS; Cooper LJ
    Front Immunol; 2014; 5():636. PubMed ID: 25566249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults.
    Fichtner AS; Bubke A; Rampoldi F; Wilharm A; Tan L; Steinbrück L; Schultze-Florey C; von Kaisenberg C; Prinz I; Herrmann T; Ravens S
    J Leukoc Biol; 2020 Jun; 107(6):1023-1032. PubMed ID: 32064671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy.
    Lavoué V; Cabillic F; Toutirais O; Thedrez A; Dessarthe B; de La Pintière CT; Daniel P; Foucher F; Bauville E; Henno S; Burtin F; Bansard JY; Levêque J; Catros V; Bouet-Toussaint F
    Int J Cancer; 2012 Aug; 131(4):E449-62. PubMed ID: 22095289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands.
    Serrano R; Coch C; Peters C; Hartmann G; Wesch D; Kabelitz D
    Sci Rep; 2021 Jul; 11(1):15231. PubMed ID: 34315922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.
    Poccia F; Malkovsky M; Pollak A; Colizzi V; Sireci G; Salerno A; Dieli F
    Mol Med; 1999 Jul; 5(7):471-6. PubMed ID: 10449808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.